David Aldrich

David Aldrich has a diverse and extensive background in medical affairs and clinical research within the pharmaceutical industry. Beginning at Johns Hopkins University as a Professor, David transitioned to Pfizer, where roles included Regulatory Affairs Manager and Medical Affairs Manager. Following this, David worked at GlaxoSmithKline in senior medical affairs positions in Australia, before moving to Eli Lilly and Company as Senior Clinical Research Physician and Neurology Clinical Development Lead. In these roles, David provided clinical direction for phases 1 through 4 of various clinical programs and successfully led efforts for the development of novel compounds. David's expertise in the CNS area culminated in a position as Medical Director ASEAN, where oversight of global clinical programs was achieved, including securing proof of concept for innovative treatments. David holds a Doctor of Medicine degree in Neuropharmacology from The Johns Hopkins University.